The Assessment of Convalescent Plasma Efficacy against COVID-19

Antibody-based therapy for infectious diseases predates modern antibiotics and, in the absence of other therapeutic options, was deployed early in the SARS-CoV-2 pandemic through COVID-19 convalescent plasma (CCP) administration. Although most studies have demonstrated signals of efficacy for CCP, d...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Med (N Y)
Prif Awduron: Casadevall, Arturo, Grossman, Brenda J., Henderson, Jeffrey P., Joyner, Michael J., Shoham, Shmuel, Pirofski, Liise-anne, Paneth, Nigel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Inc. 2020
Pynciau:
Perspective
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7747676/
https://ncbi.nlm.nih.gov/pubmed/33363284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.medj.2020.11.002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg